home / stock / lgnd / lgnd quote
Last: | $87.28 |
---|---|
Change Percent: | -0.01% |
Open: | $87.01 |
Close: | $87.28 |
High: | $88.215 |
Low: | $86.935 |
Volume: | 111,766 |
Last Trade Date Time: | 05/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$87.28 | $87.01 | $87.28 | $88.215 | $86.935 | 111,766 | 05-22-2024 |
$87 | $86.5 | $87 | $88.52 | $86.415 | 171,725 | 05-21-2024 |
$86.63 | $85.87 | $86.63 | $87.29 | $85.87 | 105,186 | 05-20-2024 |
$86.06 | $85.53 | $86.06 | $86.9 | $85.17 | 100,217 | 05-17-2024 |
$85.02 | $85.4 | $85.02 | $86.77 | $84.14 | 95,148 | 05-16-2024 |
$85.77 | $86 | $85.77 | $86.68 | $84.8 | 164,727 | 05-15-2024 |
$85.29 | $84.56 | $85.29 | $85.76 | $84.54 | 160,355 | 05-14-2024 |
$84.07 | $87.34 | $84.07 | $87.53 | $83.93 | 105,223 | 05-13-2024 |
$87.28 | $85.53 | $87.28 | $87.33 | $84.0503 | 131,450 | 05-10-2024 |
$86.12 | $79.27 | $86.12 | $86.37 | $79.27 | 494,231 | 05-09-2024 |
$80.36 | $74.37 | $80.36 | $81.43 | $72.95 | 286,949 | 05-08-2024 |
$73.22 | $73.5 | $73.22 | $75.615 | $73.155 | 162,711 | 05-07-2024 |
$72.83 | $74.05 | $72.83 | $74.7 | $72.61 | 114,774 | 05-06-2024 |
$73.9 | $73.53 | $73.9 | $74.17 | $72.57 | 141,782 | 05-03-2024 |
$72.32 | $71.77 | $72.32 | $72.7 | $70.855 | 146,548 | 05-02-2024 |
$71.42 | $70.12 | $71.42 | $72.17 | $69.51 | 115,870 | 05-01-2024 |
$69.89 | $70.4 | $69.89 | $70.8033 | $69.69 | 122,052 | 04-30-2024 |
$70.46 | $70.99 | $70.46 | $71.96 | $69.63 | 197,660 | 04-29-2024 |
$70.57 | $70.59 | $70.57 | $72.085 | $70.43 | 88,152 | 04-26-2024 |
$70.37 | $70.24 | $70.37 | $71.165 | $69.63 | 106,715 | 04-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Ligand Pharmaceuticals Incorporated Company Name:
LGND Stock Symbol:
NASDAQ Market:
Roche (OTC: RHHBY) obtained a Breakthrough Therapy Designation for its investigational oral therapy inavolisib for treating adult breast cancer pat...
Shares of Ionis Pharmaceuticals (NASDAQ: IONS) and Biogen (NASDAQ: BIIB) lost at least 2% in market cap on Thursday after the companies announced t...